Post-COVID Risk for Blood Clot Lasts at Least 6 Months

Post-COVID Risk for Blood Clot Lasts at Least 6 Months

By Robert Preidt HealthDay ReporterHealthDay Reporter THURSDAY, April 7, 2022 (HealthDay News) — COVID-19 increases people’s risk of dangerous blood clots and bleeding for months after infection, researchers say. The new findings suggest that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding. “Our findings arguably support [treatment] to avoid … Read more

CDC Panel Backs mRNA COVID Vaccines Over J&J Due to Clot Risk

CDC Panel Backs mRNA COVID Vaccines Over J&J Due to Clot Risk

Dec. 16, 2021 – A panel of experts that advises the CDC on the use of vaccines said the Pfizer and Moderna mRNA COVID-19 vaccines should be the preferred shots for adults in the U.S. because the Johnson & Johnson shot carries the risk of a rare but potentially fatal side effect that causes blood … Read more

‘Vaccine blood clot risk far smaller than Covid risks’

‘Vaccine blood clot risk far smaller than Covid risks’

The findings of a major study suggests that the increased risks of blood clotting disorders from Covid vaccines is “far smaller” than the risks associated with getting the virus. The University of Oxford-led review looked at 29 million people who’d had their first dose of the AstraZeneca or Pfizer vaccine. Prof Julia Hippisley-Cox told the … Read more

First Case of COVID-19 Triggering Recurrent Clots in Arm

First Case of COVID-19 Triggering Recurrent Clots in Arm

WEDNESDAY, May 19, 2021 (HealthDay News) — Researchers have reported the first case of COVID-19 causing dangerous, recurring blood clots in a patient’s arm. The report offers new insight into how the damage of inflammation caused by COVID-19 can linger and how best to treat recurring clots, the Rutgers University researchers said. There … Read more

Covid: Child vaccine trial paused over possible adult clot link

Covid: Child vaccine trial paused over possible adult clot link

Confirming that the trial on children was being paused, Prof Pollard said: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial.” Source link